Jim Simons Inmune Bio, Inc. Transaction History

Renaissance Technologies LLC

  • $63.6 Billion
  • Q1 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
SELL
$6.5 - $10.09 $96,200 - $149,332
-14,800 Reduced 42.53%
20,000 $182,000
Q1 2023

May 12, 2023
BUY
$6.01 - $10.18 $209,148 - $354,264
34,800 New
34,800 $225,000
Q2 2022

Aug 12, 2022
BUY
$5.48 - $8.97 $175,908 - $287,937
32,100 New
32,100 $284,000
Q4 2020

Feb 10, 2021
SELL
$7.51 - $17.22 $300,400 - $688,800
-40,000 Closed
0 $0
Q3 2020

Nov 13, 2020
BUY
$4.92 - $15.75 $196,800 - $630,000
40,000 New
40,000 $412,000

Others Institutions Holding INMB

# of Institutions
57
Shares Held
2.88M
Call Options Held
44.6K
Put Options Held
3.5K
View Full List

About Inmune Bio, Inc.

INMB Quotes by TradingView
  • Ticker INMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,946,000
  • Market Cap $145M
  • Description
  • INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...
More about INMB
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email